"According to the latest report published by Data Bridge Market Research, the Advanced Lab Reagents Market The global advanced lab reagents market size was valued at USD 2.17 billion in 2025 and is expected to reach USD 5.22 billion by 2033, at a CAGR of 11.60% during the forecast period This Advanced Lab Reagents Market research report is prepared...

"According to the latest report published by Data Bridge Market Research, the CRISPR Lipid Nanoparticle Delivery Therapeutics Market The global CRISPR Lipid Nanoparticle Delivery Therapeutics market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 5.76 billion by 2033, at a CAGR of 20.70% during the forecast period Competitive...

The global Enzymes Market size was valued at USD 14.9 billion in 2025 and is projected to grow from USD 15.8 billion in 2026 to USD 25.1 billion by 2033, registering a CAGR of 6.9% from 2026 to 2033. North America accounted for the largest revenue share of 36.3% in 2025, supported by strong biotechnology research, widespread industrial adoption, and increasing demand across food...

"According to the latest report published by Data Bridge Market Research, the Induced Pluripotent Stem Cells (iPSCs) Market The global induced pluripotent stem cells (iPSCs) market size was valued at USD 2.13 billion in 2025 and is expected to reach USD 4.53 billion by 2033, at a CAGR of 9.90% during the forecast period The persuasive Induced Pluripotent...

"According to the latest report published by Data Bridge Market Research, the Nucleic Acid-Based Drugs Market Data Bridge Market Research analyzes that the global nucleic acid-based drugs market, which was USD 32.05 million in 2022, is likely to reach USD 135.97 million by 2030 and is expected to undergo a CAGR of 19.80% during the forecast period.  The supreme Nucleic Acid-Based...

"According to the latest report published by Data Bridge Market Research, the Nucleic Acid-Based Drugs Market Data Bridge Market Research analyzes that the global nucleic acid-based drugs market, which was USD 32.05 million in 2022, is likely to reach USD 135.97 million by 2030 and is expected to undergo a CAGR of 19.80% during the forecast period.  The persuasive Nucleic...

The global Personalized Testing & Supplements Market was valued at USD 13.6 billion in 2025 and is projected to grow from USD 15.7 billion in 2026 to USD 46.3 billion by 2033, registering a remarkable CAGR of 16.7% from 2026 to 2033. The market is experiencing rapid expansion as consumers increasingly seek personalized health solutions tailored to their unique genetics,...

The global Radiation Oncology Market was valued at USD 14.0 billion in 2025 and is projected to grow from USD 15.5 billion in 2026 to USD 33.1 billion by 2033, registering a CAGR of 11.4% from 2026 to 2033. North America accounted for the largest revenue share of 46.2% in 2025, driven by the increasing prevalence of cancer, continuous technological advancements, and growing demand for...

The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

The global Synthetic Biology Market was valued at USD 18.9 billion in 2025 and is projected to grow from USD 22.1 billion in 2026 to USD 69.2 billion by 2033, registering a robust CAGR of 17.7% from 2026 to 2033. The market is witnessing significant expansion as advances in genetic engineering, genome editing, and biological system design continue to unlock new opportunities across...